Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
3.820
+0.290 (8.22%)
At close: Oct 7, 2025, 4:00 PM EDT
3.820
0.00 (0.00%)
After-hours: Oct 7, 2025, 4:00 PM EDT

Cellectis Statistics

Total Valuation

Cellectis has a market cap or net worth of $274.80 million. The enterprise value is $305.76 million.

Market Cap274.80M
Enterprise Value 305.76M

Important Dates

The next estimated earnings date is Monday, November 3, 2025, after market close.

Earnings Date Nov 3, 2025
Ex-Dividend Date n/a

Share Statistics

Cellectis has 72.33 million shares outstanding. The number of shares has increased by 41.82% in one year.

Current Share Class n/a
Shares Outstanding 72.33M
Shares Change (YoY) +41.82%
Shares Change (QoQ) -1.25%
Owned by Insiders (%) 2.20%
Owned by Institutions (%) 11.19%
Float 41.70M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 4.33
Forward PS 9.40
PB Ratio 2.83
P/TBV Ratio 2.86
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 4.82
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.38, with a Debt / Equity ratio of 0.94.

Current Ratio 1.38
Quick Ratio 0.53
Debt / Equity 0.94
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -5.80

Financial Efficiency

Return on equity (ROE) is -48.02% and return on invested capital (ROIC) is -13.26%.

Return on Equity (ROE) -48.02%
Return on Assets (ROA) -7.43%
Return on Invested Capital (ROIC) -13.26%
Return on Capital Employed (ROCE) -24.24%
Revenue Per Employee $285,757
Profits Per Employee -$265,752
Employee Count222
Asset Turnover 0.17
Inventory Turnover n/a

Taxes

In the past 12 months, Cellectis has paid $455,000 in taxes.

Income Tax 455,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +102.22% in the last 52 weeks. The beta is 3.07, so Cellectis's price volatility has been higher than the market average.

Beta (5Y) 3.07
52-Week Price Change +102.22%
50-Day Moving Average 2.94
200-Day Moving Average 1.88
Relative Strength Index (RSI) 66.96
Average Volume (20 Days) 151,693

Short Selling Information

Short Interest 257,130
Short Previous Month 209,583
Short % of Shares Out 0.49%
Short % of Float n/a
Short Ratio (days to cover) 3.19

Income Statement

In the last 12 months, Cellectis had revenue of $63.44 million and -$59.00 million in losses. Loss per share was -$0.60.

Revenue63.44M
Gross Profit 63.44M
Operating Income -45.22M
Pretax Income -58.54M
Net Income -59.00M
EBITDA -33.04M
EBIT -45.22M
Loss Per Share -$0.60
Full Income Statement

Balance Sheet

The company has $59.81 million in cash and $90.97 million in debt, giving a net cash position of -$31.16 million or -$0.43 per share.

Cash & Cash Equivalents 59.81M
Total Debt 90.97M
Net Cash -31.16M
Net Cash Per Share -$0.43
Equity (Book Value) 97.11M
Book Value Per Share 1.34
Working Capital 63.21M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$33.35 million and capital expenditures -$2.03 million, giving a free cash flow of -$35.37 million.

Operating Cash Flow -33.35M
Capital Expenditures -2.03M
Free Cash Flow -35.37M
FCF Per Share -$0.49
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -71.28% and -93.00%.

Gross Margin 100.00%
Operating Margin -71.28%
Pretax Margin -92.28%
Profit Margin -93.00%
EBITDA Margin -52.08%
EBIT Margin -71.28%
FCF Margin n/a

Dividends & Yields

Cellectis does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -41.82%
Shareholder Yield -41.82%
Earnings Yield -21.47%
FCF Yield -12.87%

Analyst Forecast

The average price target for Cellectis is $4.00, which is 4.44% higher than the current price. The consensus rating is "Buy".

Price Target $4.00
Price Target Difference 4.44%
Analyst Consensus Buy
Analyst Count 1
Revenue Growth Forecast (5Y) 26.84%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Cellectis has an Altman Z-Score of -0.95 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -0.95
Piotroski F-Score 3